transplant; chronic graft-versus-host disease; thymectomy; review Myasthenia gravis (MG) is a rare complication of allogeneic bone marrow transplantation (BMT). We present the 11th case in the medical literature, a 23-Myasthenia gravis (MG) is a neuromuscular disorder year-old female 100 months post-allogeneic bone marcharacterized clinically by weakness and pathologic fatirow transplantation for acute myelogenous leukemia gability of skeletal muscle. The underlying pathophysio-(AML). After discontinuation of immunosuppression logy is that of a decrease in the number of acetylcholine for chronic graft-versus-host disease (GVHD) involving receptors (AChRs) at the neuromuscular junction, due to skin, gastrointestinal tract and lacrimal glands, the circulating autoantibodies directed at the acetylcholine patient developed severe, progressive dysphagia initially receptor (anti-AChR antibodies). Muscle weakness often attributed to esophageal candidiasis. With the developinvolves the eyelids, extraocular muscles, facial and bulbar ment of muscle weakness, ptosis, and dysphonia the musculature, but can be generalized and involve the proxidiagnosis of generalized myasthenia gravis was susmal limb muscles as well. The diagnosis is made on clinical pected, and confirmed by elevated anti-acetylcholine grounds supported by electrodiagnostic testing, elevated receptor antibody titer and a positive edrophonium titers of anti-AChR antibodies, and improvement in challenge. Prednisone and pyridostigmine produced strength with anticholinesterase therapy. Treatment is effecimprovement, and thymectomy was performed without tive in the majority of patients, and includes enhancement pathologic evidence of thymoma. Recurrent post-operof neuromuscular transmission with anticholinesterase ative respiratory distress required transient mechanical medications, thymectomy, immunosuppression (cortiventilation. Twenty-seven months after diagnosis, the costeroids, azathioprine, cyclosporine) and short-term patient requires maintenance prednisone to control immunomodulation (plasmapheresis and intravenous symptoms of myasthenia gravis. The clinical features of immune globulin). 1 Myasthenia gravis is an autoimmune all reported cases of MG post-allogeneic BMT are disease rarely diagnosed in the post-allogeneic bone marreviewed, and universal features include an association row transplantation (BMT) setting. It may be part of the with decreasing immunosuppression, the presence of spectrum of chronic graft-versus-host disease (GVHD), 2 other manifestations of chronic GVHD, anti-acetylchoand is associated with discontinuation of immunosuppresline receptor antibodies, and the absence of an associasion. 3 We report a patient with chronic GVHD who ted thymoma. HLA Cw1, Cw7 and DR2 were identified developed MG 100 months after allogeneic BMT for AML. at frequencies significantly above that expected from HLA antigen prevalance studies, and may be markers for increased risk of developing MG post-allogeneic Case report BMT. No statistically significant associations with HLA A2, B7, B35 or donor-recipient sex mismatch were present. Reinstitution of immunosuppression and stan-A 15-year-old Caucasian female with AML in first remission underwent BMT from an HLA-identical sister in dard therapies for myasthenia gravis were effective in the majority of cases. The role of thymectomy in this October 1985. Her initial post-transplant course was complicated by bacterial septicemia, Pneumocystis carinii population remains unclear. Keywords: myasthenia gravis; allogeneic bone marrow pneumonia, deep venous thrombosis, and a small intracranial hemorrhage leading to residual right hand weakness after craniotomy and aneurysm clipping. Chronic GVHD involving the intestinal tract, liver, cornea and skin
mation of the anterior chamber. The patient was treated Discussion with prednisone and azathioprine. Prednisone was tapered Myasthenia gravis is a rare complication of allogeneic bone gradually to discontinuation by January 1993, while marrow transplantation, with only 11 well-documented azathioprine was discontinued in March 1993. cases in the world literature [2] [3] [4] [5] [6] [7] [8] [9] (and Sullivan KM, personal In February 1994, she presented to hospital with a 6-communication; Atkinson K, personal communication). On week history of progressive dysphagia with some pharynreview of the specifics of the reported cases of myasthenia geal discomfort and nasal regurgitation, dysphonia, dimingravis associated with BMT (Table 1) , it is striking that ished vocal volume with repetition and shoulder girdle each case was invariably associated with chronic GVHD muscular weakness. The symptoms were worse towards the (with seven of the 11 cases having skin involvement and end of the day. Family members had noticed intermittent sicca syndrome), and tapering of immunosuppression. ptosis. She had recently been presumptively diagnosed with A statistical analysis of potential risk factors for the esophageal candidiasis and was taking oral fluconazole, development of MG post-BMT was done (Table 2) . Using nystatin suspension, an oral contraceptive pill and flavoxate the binomial theorum and published HLA antigen frehydrochloride. A paternal grandfather developed myasquencies in various racial groups, 10,11 we were able to deterthenia gravis at age 53 and had died in a myasthenic crisis mine if specific HLA antigens were present in these patients only weeks after diagnosis. There were no other family at frequencies significantly above that expected by chance. members with autoimmune illnesses.
HLA Cw1, Cw7 and DR2 were identified at frequencies The patient was clinically dehydrated and had oropharynsignificantly above that expected from HLA antigen prevageal candidiasis. Visual acuity was markedly decreased lence studies, and may be markers for increased risk of bilaterally due to corneal scarring. Bilateral ptosis and left developing MG post-allogeneic BMT. These HLA associophthalmoplegia with absent abduction and impaired vertiations are discordant with those observed in idiopathic cal gaze were present, as was severe bifacial weakness. myasthenia gravis: HLA B8, DRw3, and DQw2. 12, 13 The Nasal dysarthric speech, diffuse weakness worse in her previously reported features identifying those patients at arms, and fatigue with repetitive strength testing was noted.
high risk for developing myasthenia gravis (HLA A2, B7, She was able to count to only 20 with one breath. Bibasilar B35, donor-recipient sex mismatch) 8 were not shown to be inspiratory crackles were noted. Cardiovascular and statistically significant in this analysis. abdominal examination were otherwise normal. DermatoSix of 11 patients were transplanted for aplastic anemia. logic changes consistent with quiescent chronic GVHD A positive family history for MG was documented only in were present. our case. Given the nonspecificity of these risk factors, it The patient received intravenous fluids with resolution would appear difficult reliably to predict which patients are of signs of dehydration. Upper gastrointestinal endoscopy at high risk for this rare complication of allogeneic BMT. was performed which did not reveal esophageal candidiasis
The clinician is advised to keep a high index of suspicion or ulceration, but did demonstrate mild esophagitis. Vital in those patients who complain of weakness, dysphagia, capacity was 1.77 litres (50% of predicted). There was a dyplopia or ptosis in the clinical setting of tapering dramatic response to 2 mg edrophonium with correction of immunosuppression and prior chronic GVHD. the ptosis and ophthalmoplegia, and improved strength in
In the appropriate clinical setting, the universal presence face and limb muscles. Pyridostigmine and prednisone were of antibodies to the acetylcholine receptor and dramatic response to edrophonium challenge should make this diagbegun with symptomatic improvement and increase in vital nosis relatively straightforward. The one caveat is the capacity to 2.6 litres (75% of predicted). Repetitive nerve reported high incidence of elevated anti-AChR antibody titstimulation studies of the right ulnar median and peroneal ers in allogeneic BMT recipients without clinical features motor nerves were inconclusive, probably due to the of myasthenia gravis, 14 which would lead to a low positive initiation of therapy 48 h prior to the study. Anti-AChR predictive value in a patient with atypical symptoms and/or antibody titers determined by radioimmunoassay were elevfew signs. In such a setting, edrophonium challenge or elecated at 4411 c.p.m. (upper limit of normal 2062, mean + tromyography may be of more diagnostic utility than antis.d.: 1730 + 166).
ACH receptor antibody determinations. CT of thorax failed to reveal thymoma and pathologic Standard myasthenia gravis therapies appear to have examination of a subsequent thymectomy specimen showed been effective in this setting, and have included pyridostigno evidence of malignancy. The patient was extubated postmine, prednisone, azathioprine, cyclosporine and plasmaoperatively without difficulty, but 7 days post-operatively pheresis. Thymectomy was reported in our patient, without she developed a myasthenic crisis with recurrent dysphagia histologic evidence of thymoma. There have been no and respiratory distress requiring tracheal intubation and reports of an association of thymoma and myasthenia gravis short-term mechanical ventilation.
in the post-allogeneic BMT setting. The patient has since successfully discontinued pyridoCurrent recommendations for management of genstigmine, but symptoms of myasthenia gravis recurred on eralized myasthenia gravis in the non-transplant setting are steroid tapering. She remains on prednisone 10 mg daily for early aggressive treatment with thymectomy and 27 months after the diagnosis of myasthenia gravis. The immunosuppression, which have demonstrated high rates sibling donor has no symptoms of myasthenia gravis or of remission in non-randomized studies. However, despite other autoimmune conditions, and has normal anti-acetylresponses to therapy in all cases reported to date, the course choline receptor antibody titers.
of the illness can be life-threatening, with one other vincing retrospective study, thymectomy alone produced
